Items where the Publication is BRITISH JOURNAL OF DERMATOLOGY

Number of items: 8.
2021
  • Incidence of acute complications of herpes zoster among immunocompetent adults in England: a matched cohort study using routine health data. (2021) Forbes, HJ; Bhaskaran, K; Grint, D; Hu, VH; Langan, SM; McDonald, HI; Morton, C; Smeeth, L; Walker, JL; Warren-Gash, C
  • 2020
  • The 2020 International Alliance for the Control of Scabies Consensus Criteria for the Diagnosis of Scabies. (2020) Engelman, D; Yoshizumi, J; Hay, RJ; Osti, M; Micali, G; Norton, S; Walton, S; Boralevi, F; Bernigaud, C; Bowen, AC; Chang, AY; Chosidow, O; Estrada-Chavez, G; Feldmeier, H; Ishii, N; Lacarrubba, F; Mahé, A; Maurer, T; Mahdi, MMA; Murdoch, ME; Pariser, D; Nair, PA; Rehmus, W; Romani, L; Tilakaratne, D; Tuicakau, M; Walker, SL; Wanat, KA; Whitfeld, MJ; Yotsu, RR; Steer, AC; Fuller, LC
  • The association of smoking and socioeconomic status on cutaneous melanoma: a population-based, data-linkage, case-control study. (2020) Gibson, JAG; Dobbs, TD; Griffiths, R; Song, J; Akbari, A; Whitaker, S; Watkins, A; Langan, SM; Hutchings, HA; Lyons, RA; Whitaker, IS description
  • Incidence, prevalence and mortality of bullous pemphigoid in England 1998-2017: a population-based cohort study. (2020) Persson, MSM; Harman, KE; Vinogradova, Y; Langan, SM; Hippisley-Cox, J; Thomas, KS; Gran, S
  • Risk of hospitalization and death due to infection in people with psoriasis: a population-based cohort study using the Clinical Practice Research Datalink. (2020) Yiu, ZZN; Parisi, R; Lunt, M; Warren, RB; Griffiths, CEM; Langan, SM; Ashcroft, DM
  • 2019
  • Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study. (2019) Warren, RB; Marsden, A; Tomenson, B; Mason, KJ; Soliman, MM; Burden, AD; Reynolds, NJ; Stocken, D; Emsley, R; Griffiths, CEM; Smith, C; PSORT Consortium and on behalf of the BADBIR Study Group
  • Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR). (2019) Yiu, ZZN; Ashcroft, DM; Evans, I; McElhone, K; Lunt, M; Smith, CH; Walton, S; Murphy, R; Reynolds, NJ; Ormerod, AD; Griffiths, CEM; Warren, RB; BADBIR Study Group
  • A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real-world populations in psoriasis. (2019) Yiu, ZZN; Mason, KJ; Barker, JNWN; Hampton, PJ; McElhone, K; Smith, CH; Warren, RB; Griffiths, CEM; Lunt, M; Burden, AD; BADBIR Study Group